Skip to main content
SpringerLink
Log in

Reply to: Microvascular hypertensive disease, long COVID, and end-organ pathology

  • Correspondence
  • Published:
Hypertension Research Submit manuscript

The Original Article was published on 13 July 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto K, et al. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res. 2023;46:601–19.

    Article  PubMed  Google Scholar 

  2. Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529.

    Article  PubMed  Google Scholar 

  3. Daugherty SE, Guo Y, Heath K, Dasmarinas MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.

    Article  PubMed  Google Scholar 

  4. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259–64.

    Article  CAS  PubMed  Google Scholar 

  5. Sarmiento Varón L, González-Puelma J, Medina-Ortiz D, Aldridge J, Alvarez-Saravia D, Uribe-Paredes R, et al. The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management. Front Public Health. 2023;11:1140353.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Health Surveillance & Preventive Medicine, Tokyo Medical University Hospital, Tokyo, Japan

    Chisa Matsumoto

  2. Department of Cardiology, Tokyo Medical University, Tokyo, Japan

    Chisa Matsumoto

Authors
  1. Chisa Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Japanese Society of Hypertension project team on COVID-19

Corresponding author

Correspondence to Chisa Matsumoto.

Ethics declarations

Conflict of interest

The author declares no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsumoto, C., on behalf of the Japanese Society of Hypertension project team on COVID-19. Reply to: Microvascular hypertensive disease, long COVID, and end-organ pathology. Hypertens Res 46, 2249–2250 (2023). https://doi.org/10.1038/s41440-023-01371-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01371-2

  • Springer Nature Singapore Pte Ltd.

Keywords

Search

Navigation